Deep learning to estimate RECIST in patients with NSCLC treated with PD-1 blockade

Real-world evidence (RWE) – conclusions derived from analysis of patients not treated in clinical trials – is increasingly recognized as an opportunity for discovery, to reduce disparities, and to contribute to regulatory approval. Maximal value of RWE may be facilitated through machine learning tec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Discov
Main Authors: Arbour, Kathryn C., Luu, Anh Tuan, Luo, Jia, Rizvi, Hira, Plodkowski, Andrew J., Sakhi, Mustafa, Huang, Kevin B., Digumarthy, Subba R., Ginsberg, Michelle S., Girshman, Jeffrey, Kris, Mark G., Riely, Gregory J., Yala, Adam, Gainor, Justin F., Barzilay, Regina, Hellmann, Matthew D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7981277/
https://ncbi.nlm.nih.gov/pubmed/32958579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-20-0419
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados